Gamma Hydroxybutyrate (GHB) and Gamma Butyrolactone (GBL) Withdrawal: Five Case Studies
作者： Charles H. McDaniel , Karen A. Miotto
DOI: 10.1080/02791072.2001.10400479
关键词: gamma-Butyrolactone 、 Anesthesia 、 Withdrawal syndrome 、 AUTONOMIC INSTABILITY 、 After treatment 、 Medical information 、 Psychology 、 Gamma hydroxybutyrate 、 Delirium
摘要: There is little medical information available about gamma- hydroxybutyrate (GHB) or gamma-butyrolactone (GBL) dependence withdrawal. In this study the authors treated and reviewed multiple cases of GHB GBL withdrawal in high-dose users. Five patients during nine hospitalizations were for The describe a spectrum from mild to severe discuss medications used treatment. They conclude that with may present agitated psychosis, delirium, autonomic instability. sample, relapse use occurred soon after treatment
sci-hub.se 参考文章(32)
Marc I Rosen, H Rowland Pearsall, Scott W Woods, Thomas R Kosten, The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal Neuropsychopharmacology. ,vol. 14, pp. 187- 193 ,(1996) , 10.1016/0893-133X(95)00087-T
Luigi Gallimberti, Mauro Cibin, Piero Pagnin, Roberta Sabbion, Pier Paolo Pani, Roberto Pirastu, Santo Davide Ferrara, Gian Luigi Gessa, Gamma-Hydroxybutyric Acid for Treatment of Opiate Withdrawal Syndrome Neuropsychopharmacology. ,vol. 9, pp. 77- 81 ,(1993) , 10.1038/NPP.1993.45
Christopher D. Cash, Gammahydroxybutyrate: An overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent Neuroscience & Biobehavioral Reviews. ,vol. 18, pp. 291- 304 ,(1994) , 10.1016/0149-7634(94)90031-0
Luigi Gallimberti, Maurizio Raffaele Spella, Carlo Alberto Soncini, Gian Luigi Gessa, Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol. ,vol. 20, pp. 257- 262 ,(2000) , 10.1016/S0741-8329(99)00089-0
SD Ferrara, S Zotti, L Tedeschi, G Frison, F Castagna, L Gallimberti, GL Gessa, P Palatini, Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. British Journal of Clinical Pharmacology. ,vol. 34, pp. 231- 235 ,(1992) , 10.1111/J.1365-2125.1992.TB04129.X
Giancarlo Colombo, Roberta Agabio, Jacques Bourguignon, Fabio Fadda, Carla Lobina, Michel Maitre, Roberta Reali, Martine Schmitt, Gian Luigi Gessa, Blockade of the discriminative stimulus effects of γ-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382 Physiology & Behavior. ,vol. 58, pp. 587- 590 ,(1995) , 10.1016/0031-9384(95)00086-X
FLAVIO Poldrugo, GIOVANNI Addolorato, The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies. Alcohol and Alcoholism. ,vol. 34, pp. 15- 24 ,(1999) , 10.1093/ALCALC/34.1.15
Luigi Gallimberti, Fabrizio Schifano, Giovanni Forza, Lorella Miconi, S. Davide Ferrara, Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. European Archives of Psychiatry and Clinical Neuroscience. ,vol. 244, pp. 113- 114 ,(1994) , 10.1007/BF02191883
Jo Ellen Dyer, γ-Hydroxybutyrate: A health-food product producing coma and seizurelike activity The American Journal of Emergency Medicine. ,vol. 9, pp. 321- 324 ,(1991) , 10.1016/0735-6757(91)90050-T
G.P Galloway, S.L Frederick-Osborne, Richard Seymour, Sarah E Contini, David E Smith, Abuse and therapeutic potential of gamma-hydroxybutyric acid. Alcohol. ,vol. 20, pp. 263- 269 ,(2000) , 10.1016/S0741-8329(99)00090-7